Meningococcal Disease Completed Phase 4 Trials for Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen (DB14427)

IndicationStatusPhase
DBCOND0033309 (Meningococcal Disease)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01766206Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South KoreaPrevention